EP Patent

EP2021008B1 — Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8

Assigned to Aceragen Inc · Expires 2015-12-02 · 10y expired

What this patent protects

Patent listed against inclisiran-sodium.

Drugs covered by this patent

inclisiran-sodium (INCLISIRAN SODIUM)

Patent Metadata

Patent number: EP2021008B1
Jurisdiction: EP
Classification: —
Expires: 2015-12-02
Drug substance claim: No
Drug product claim: No
Assignee: Aceragen Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.